HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

‘Serial Acquirers’ In Cosmetics Sector Create More Value – A.T. Kearney Report

This article was originally published in The Rose Sheet

Executive Summary

The enterprise-value growth rate of beauty and personal-care players that completed two or more acquisitions annually during the 2010-2016 period is 26% higher than that for less frequent buyers, the consulting firm notes in a recent report. Translation: “Shop or Drop,” its analysts say.

You may also be interested in...



NPD Forecast: Makeup Highs, Millennials Should Stay Covered

Market research firm NPD Group predicts that makeup will continue to dominate the prestige beauty market in 2017, reflecting “the selfie-obsessed, image-driven, influencer-made culture of our time.”

Portfolio Firm Glansaol Looks To Make Mark In Prestige, Led By Ex-Revlon CEO

More deals may be on the horizon for portfolio company Glansaol following its announced market entry with the acquisition of three prestige brands.

Cosmetic News In Brief: Unilever Nabs Living Proof; TINA.org’s ‘Naughty’ List; More

Unilever will add Living Proof hair care to its prestige portfolio through an acquisition expected to close in the 2017 first quarter; Memebox raises $60m in new funding; WEN and The Honest Company make nonprofit Truth In Advertising’s 2016 “naughty” list. More cosmetics news in brief.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108969

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel